ResearcherUniversity of CambridgeNo recent work listed

Ljiljana Fruk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2104-5817; OpenAlex author ID A5031178143. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. Last author DOI 10.1039/d2nr00864e ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrea Bistrović Popov · 1 shared paper, 2022 · strength 0.14
- Paper Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. DOI 10.1039/d2nr00864e ↗
Francesca Melle · 1 shared paper, 2022 · strength 0.14
- Paper Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. DOI 10.1039/d2nr00864e ↗
David Fairen‐Jiménez · 1 shared paper, 2022 · strength 0.14
- Paper Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. DOI 10.1039/d2nr00864e ↗
Frances M. Richards · 1 shared paper, 2022 · strength 0.14
- Paper Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. DOI 10.1039/d2nr00864e ↗
Duncan Ian Jodrell · 1 shared paper, 2022 · strength 0.14
- Paper Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. DOI 10.1039/d2nr00864e ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.